Hydroxychloroquine for pre-exposure prophylaxis of COVID-19 in health care workers: a randomized, multicenter, placebo-controlled trial Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine (HERO-HCQ)

By sjmartinez • March 22, 2023

Naggie S, Milstone A, Castro M, Collins SP, Lakshmi S, Anderson DJ, Cahuayme-Zuniga L, Turner KB, Cohen LW, Currier J, Fraulo E, Friedland A, Garg J, George A, Mulder H, Olson RE, O'Brien EC, Rothman RL, Shenkman E, Shostak J, Woods CW, Anstrom KJ, Hernandez AF; HERO Research Program. Hydroxychloroquine for pre-exposure prophylaxis of COVID-19 in health care workers: a randomized, multicenter, placebo-controlled trial Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine (HERO-HCQ). Int J Infect Dis. 2023 Apr;129:40-48. doi: 10.1016/j.ijid.2023.01.019. Epub 2023 Jan 20. PMID: 36682681; PMCID: PMC9851717.

Tags: covid-19, Health care workers, hydroxychloroquine, Infectious Diseases, prevention, Publications, Trial design

A novel risk-adjusted metric to compare hospitals on their antibiotic-prescribing at hospital discharge

Livorsi DJ, Merchant JA, Cho H, Goetz MB, Alexander B, Beck B, Goto M. A novel risk-adjusted metric to compare hospitals on their antibiotic-prescribing at[...]

Severe flea-borne typhus complicated by hemophagocytic lymphohistiocytosis: A case report and review of literature

Zamora Gonzalez RA, Mayo MS, Jeng AC. Severe flea-borne typhus complicated by hemophagocytic lymphohistiocytosis: A case report and review of literature. IDCases. 2024 Apr 15;36:e01955.[...]

Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody

Phan T, Zitzmann C, Chew KW, Smith DM, Daar ES, Wohl DA, Eron JJ, Currier JS, Hughes MD, Choudhary MC, Deo R, Li JZ, Ribeiro[...]